共 50 条
Evidence that MIG-6 is a tumor-suppressor gene
被引:0
|作者:
Y-W Zhang
B Staal
Y Su
P Swiatek
P Zhao
B Cao
J Resau
R Sigler
R Bronson
G F Vande Woude
机构:
[1] Laboratory of Molecular Oncology,Division of Pfizer
[2] Van Andel Research Institute,Department of Pathology
[3] Laboratory of Germline Modification,undefined
[4] Van Andel Research Institute,undefined
[5] Laboratory of Antibody Technology,undefined
[6] Van Andel Research Institute,undefined
[7] Laboratory of Analytical,undefined
[8] Cellular,undefined
[9] and Molecular Microscopy,undefined
[10] Van Andel Research Institute,undefined
[11] Esperion Therapeutics,undefined
[12] Harvard Medical School,undefined
来源:
关键词:
MIG-6;
mutation;
lung carcinogenesis;
signal transduction;
EGF;
HGF/SF;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Mitogen-inducible gene 6 (MIG-6) is located in human chromosome 1p36, a locus frequently associated with human lung cancer. MIG-6 is a negative regulator of epidermal growth factor (EGF) signaling, and we show that Mig-6 – like EGF – is induced by hepatocyte growth factor/scatter factor (HGF/SF) in human lung cancer cell lines. Frequently, the receptors for both factors, EGFR and Met, are expressed in same lung cancer cell line, and MIG-6 is induced by both factors in a mitogen-activated protein kinase-dependent fashion. However, not all tumor lines express MIG-6 in response to either EGF or HGF/SF. In these cases, we find missense and nonsense mutations in the MIG-6 coding region, as well as evidence for MIG-6 transcriptional silencing. Moreover, germline disruption of Mig-6 in mice leads to the development of animals with epithelial hyperplasia, adenoma, and adenocarcinoma in organs like the lung, gallbladder, and bile duct. These data suggests that MIG-6 is a tumor-suppressor gene and is therefore a candidate gene for the frequent 1p36 genetic alterations found in lung cancer.
引用
收藏
页码:269 / 276
页数:7
相关论文